ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

ClinicalTrials.gov ID: NCT00460811

Public ClinicalTrials.gov record NCT00460811. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 3, 2026, 4:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multicenter, Double-blind, Placebo-controlled, Dose-range-finding, Parallel-design, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Irritable Bowel Syndrome With Constipation

Study identification

NCT ID
NCT00460811
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ironwood Pharmaceuticals, Inc.
Industry
Enrollment
420 participants

Conditions and interventions

Interventions

  • Linaclotide Acetate Drug
  • Matching placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2007
Primary completion
Jan 31, 2008
Completion
Mar 31, 2008
Last update posted
Feb 3, 2013

2007 – 2008

United States locations

U.S. sites
79
U.S. states
32
U.S. cities
79
Facility City State ZIP Site status
Microbia Investigational Site Huntsville Alabama 35801
Microbia Investigational Site Chandler Arizona
Microbia Investigational Site Tuscon Arizona
Microbia Investigational Site Sherwood Arkansas
Microbia Investigational Site Anaheim California
Microbia Investigational Site Garden Grove California
Microbia Investigational Site Sacramento California
Microbia Investigational Site San Diego California
Microbia Investigational Site Bristol Connecticut
Microbia Investigational Site Boynton Beach Florida
Microbia Investigational Site Dunedin Florida
Microbia Investigational Site Largo Florida
Microbia Investigational Site Ocala Florida
Microbia Investigational Site Port Orange Florida
Microbia Investigational Site Stuart Florida
Microbia Investigational Site Tampa Florida 33607
Microbia Investigational Site Stockbridge Georgia
Microbia Investigational Site Libertyville Illinois
Microbia Investigational Site Peoria Illinois 60601
Microbia Investigational Site Clive Iowa
Microbia Investigational Site Davenport Iowa
Microbia Investigational Site Mission Kansas
Microbia Investigational Site Shawnee Kansas
Microbia Investigational Site Baton Rouge Louisiana
Microbia Investigational Site Monroe Louisiana 71201
Microbia Investigational Site West Monroe Louisiana
Microbia Investigational Site Annapolis Maryland
Microbia Investigational Site Silver Spring Maryland
Microbia Investigational Site Fall River Massachusetts
Microbia Investigational Site Ann Arbor Michigan
Microbia Investigational Site St Louis Missouri
Microbia Investigational Site Missoula Montana
Microbia Investigational Site Henderson Nevada
Microbia Investigational Site Las Vegas Nevada
Microbia Investigational Site Blackwood New Jersey
Microbia Investigational Site Great Neck New York 11020
Microbia Investigational Site Pittsford New York
Microbia Investigational Site Asheville North Carolina
Microbia Investigational Site Chapel Hill North Carolina
Microbia Investigational Site Elkin North Carolina
Microbia Investigational Site Greensboro North Carolina
Microbia Investigational Site Harrisburg North Carolina
Microbia Investigational Site Hickory North Carolina
Microbia Investigational Site Raleigh North Carolina
Microbia Investigational Site Statesville North Carolina
Microbia Investigational Site Winston-Salem North Carolina
Microbia Investigational Site Cincinnati Ohio
Microbia Investigational Site Cleveland Ohio
Microbia Investigational Site Dayton Ohio
Microbia Investigational Site Sylvania Ohio
Microbia Investigational Site Oklahoma City Oklahoma
Microbia Investigational Site Tulsa Oklahoma
Microbia Investigational Site Yukon Oklahoma
Microbia Investigational Site Medford Oregon
Microbia Investigational Site Levittown Pennsylvania
Microbia Investigational Site Pittsburgh Pennsylvania
Microbia Investigational Site Reading Pennsylvania
Microbia Investigational Site Sellersville Pennsylvania 18960
Microbia Investigational Site Anderson South Carolina
Microbia Investigational Site Mt. Pleasant South Carolina
Microbia Investigational Site Simpsonville South Carolina
Microbia Investigational Site Summerville South Carolina
Microbia Investigational Site Bristol Tennessee
Microbia Investigational Site Germantown Tennessee
Microbia Investigational Site Jackson Tennessee
Microbia Investigational Site Kingsport Tennessee
Microbia Investigational Site Beaumont Texas
Microbia Investigational Site Corsicana Texas
Microbia Investigational Site El Paso Texas
Microbia Investigational Site San Antonio Texas
Microbia Investigational Site Ogden Utah
Microbia Investigational Site Chesapeake Virginia
Microbia Investigational Site Lynchburg Virginia
Microbia Investigational Site Richmond Virginia
Microbia Investigational Site Lakewood Washington
Microbia Investigational Site Olympia Washington
Microbia Investigational Site Vancouver Washington
Microbia Investigational Site Charleston West Virginia
Microbia Investigational Site La Crosse Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00460811, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 3, 2013 · Synced May 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00460811 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →